MARK-AGE: European study to establish biomarkers of human ageing

MARK-AGE: European study to establish biomarkers of human ageing - MARK-AGE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32753

Enrollment

270

Registered

2008-10-20

Start date

2009-02-01

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

offspring of long-living subjects and their partners ageing

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Offspring of longliving sibpair or spouse of sibpairs previously included in the GEHA-study

Exclusion criteria

Exclusion criteria: use of antibiotics, cortisone-based drugs and/or anti-inflamatory drugs in the week before the visit

Design outcomes

Primary

Measure	Time frame
The outcome parameters include DNA-based markers, protein-based markers, immunological markers, clinical chemical markers, hormones, and markers of metabolism and oxidative stress.	—

Countries

Netherlands

Outcome results